T1	Condition 0 9	Rest pain
T2	Condition 13 24	tissue loss
T3	Condition 32 35	PAD
T4	Measurement 37 51	Fontaine stage
T5	Value 52 55	III
T6	Value 60 62	IV
*	OR T5 T6
T7	Scope 52 62	III and IV
R1	Has_scope Arg1:T4 Arg2:T7	
*	OR T1 T2
T8	Scope 0 24	Rest pain or tissue loss
R2	AND Arg1:T8 Arg2:T3	
R3	AND Arg1:T8 Arg2:T4	
T9	Qualifier 66 71	acute
T10	Qualifier 72 87	lower extremity
T11	Condition 88 102	ischemic event
R4	Has_qualifier Arg1:T11 Arg2:T10	
R5	Has_qualifier Arg1:T11 Arg2:T9	
T12	Qualifier 103 138	secondary to thromboembolic disease
T13	Qualifier 103 115;142 154	secondary to acute trauma
T14	Condition 116 138	thromboembolic disease
T15	Condition 142 154	acute trauma
R6	multi Arg1:T13 Arg2:T15	
R7	multi Arg1:T12 Arg2:T14	
*	OR T13 T12
T16	Scope 103 154	secondary to thromboembolic disease or acute trauma
R8	Has_scope Arg1:T11 Arg2:T16	
T17	Measurement 157 173	Walking capacity
T18	Value 174 195	significantly limited
R9	Has_value Arg1:T17 Arg2:T18	
T19	Condition 221 233	claudication
T20	Negation 210 220	other than
R10	Has_negation Arg1:T19 Arg2:T20	
T21	Condition 244 247;319 328	leg pathology
T22	Condition 288 296;319 328	systemic pathology
*	OR T21 T22
T23	Qualifier 249 254	joint
T24	Qualifier 255 270	musculoskeletal
T25	Qualifier 272 282	neurologic
*	OR T23 T24 T25
T26	Scope 249 282	joint/musculoskeletal, neurologic
R11	Has_scope Arg1:T21 Arg2:T26	
T27	Condition 298 303;310 317	heart disease
T28	Condition 305 317	lung disease
*	OR T27 T28
T29	Scope 298 317	heart, lung disease
R12	Subsumes Arg1:T22 Arg2:T29	
T30	Scope 244 328	leg (joint/musculoskeletal, neurologic) and systemic (heart, lung disease) pathology
T31	Condition 199 233	conditions other than claudication
T32	Qualifier 210 233	other than claudication
R13	multi Arg1:T31 Arg2:T32	
R14	multi Arg1:T32 Arg2:T19	
R15	AND Arg1:T31 Arg2:T17	
R16	Has_scope Arg1:T31 Arg2:T30	
T34	Drug 353 367	ACE inhibitors
T33	Temporal 331 342	Current use
T35	Drug 371 403	angiotensin II receptor blockers
*	OR T34 T35
T36	Scope 353 403	ACE inhibitors or angiotensin II receptor blockers
R17	Has_temporal Arg1:T36 Arg2:T33	
T37	Condition 406 428	Chronic kidney disease
T38	Measurement 434 470	estimated Glomerular Filtration Rate
T39	Value 471 490	< 30 ml/min/1.73 m2
R18	Has_value Arg1:T38 Arg2:T39	
R19	AND Arg1:T37 Arg2:T38	
T40	Observation 493 500	History
T41	Qualifier 504 513	bilateral
T42	Qualifier 514 520	severe
T43	Condition 521 542	renal artery stenosis
R20	Has_qualifier Arg1:T43 Arg2:T42	
R21	Has_qualifier Arg1:T43 Arg2:T41	
T44	Observation 550 557	History
T45	Condition 561 571	angioedema
T46	Temporal 583 591	previous
T47	Procedure 592 615	ACE-inhibitor treatment
T48	Drug 592 605	ACE-inhibitor
R22	multi Arg1:T47 Arg2:T48	
T49	Qualifier 619 624	known
T50	Condition 625 641	hypersensitivity
T51	Drug 645 653	ramipril
T52	Drug 663 677	ACE inhibitors
*	OR T51 T52
T53	Scope 645 677	ramipril or other ACE inhibitors
R23	Has_scope Arg1:T50 Arg2:T53	
R24	Has_qualifier Arg1:T50 Arg2:T49	
R25	Has_temporal Arg1:T47 Arg2:T46	
*	OR T50 T47
T54	Scope 583 677	previous ACE-inhibitor treatment or known hypersensitivity to ramipril or other ACE inhibitors
R26	Has_scope Arg1:T45 Arg2:T54	
R27	Has_temporal Arg1:T45 Arg2:T44	
*	OR T43 T45
R28	Has_temporal Arg1:T43 Arg2:T40	
